Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9976
CALL
Kingstone Companies
KINS
$290M
| $210K | ﹤0.01% |
22,900
+4,500
| +24% | +$34.8K |
|
9977
PUT
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.4B
| $209K | ﹤0.01% |
4,600
+4,400
| +2,200% | +$193K |
|
9978
PUT
Invesco S&P 500 GARP ETF
SPGP
$2.32B
| $209K | ﹤0.01% |
2,000
+1,900
| +1,900% | +$194K |
|
|
BRDG
9979
PUT
DELISTED
Bridge Investment Group
BRDG
| $209K | ﹤0.01% |
21,200
-30,100
| -59% | -$246K |
|
9980
Citizens
CIA
$199M
| $209K | ﹤0.01% |
57,758
+42,690
| +283% | +$125K |
|
9981
CALL
Arbutus Biopharma
ABUS
$940M
| $209K | ﹤0.01% |
54,300
+30,600
| +129% | +$117K |
|
9982
CALL
Pulse Biosciences
PLSE
$3.29B
| $209K | ﹤0.01% |
11,900
+2,100
| +21% | +$35.8K |
|
9983
PUT
Delcath Systems
DCTH
$582M
| $209K | ﹤0.01% |
23,100
-11,800
| -34% | -$102K |
|
9984
Kingsbarn Tactical Bond ETF
KDRN
$2.31M
| $209K | ﹤0.01% |
+8,776
| New | +$206K |
|
9985
CALL
Orion Group Holdings
ORN
$399M
| $208K | ﹤0.01% |
36,100
+13,200
| +58% | +$102K |
|
9986
PUT
Zentalis Pharmaceuticals
ZNTL
$263M
| $208K | ﹤0.01% |
56,600
+50,000
| +758% | +$182K |
|
9987
Alico
ALCO
$295M
| $208K | ﹤0.01% |
+7,444
| New | +$206K |
|
9988
PUT
Absci
ABSI
$1.52B
| $208K | ﹤0.01% |
54,500
-29,200
| -35% | -$116K |
|
9989
Domo
DOMO
$182M
| $208K | ﹤0.01% |
27,697
-145,099
| -84% | -$1.11M |
|
9990
PUT
ProShares Ultra Technology
ROM
$1.34B
| $208K | ﹤0.01% |
+3,100
| New | +$201K |
|
9991
CALL
PACS Group
PACS
$7B
| $208K | ﹤0.01% |
5,200
+2,200
| +73% | +$80K |
|
|
SCS
9992
PUT
DELISTED
Steelcase
SCS
| $208K | ﹤0.01% |
15,400
+10,200
| +196% | +$137K |
|
|
ARI
9993
PUT
Apollo Commercial Real Estate
ARI
$881M
| $208K | ﹤0.01% |
22,600
-9,200
| -29% | -$93.8K |
|
9994
PUT
Crane NXT
CXT
$2.93B
| $208K | ﹤0.01% |
3,700
+1,000
| +37% | +$58.1K |
|
|
DPG
9995
Duff & Phelps Utility and Infrastructure Fund
DPG
$531M
| $208K | ﹤0.01% |
+17,678
| New | +$191K |
|
9996
PUT
Core Laboratories
CLB
$575M
| $208K | ﹤0.01% |
11,200
+4,700
| +72% | +$94.4K |
|
|
MMD
9997
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$281M
| $208K | ﹤0.01% |
+12,309
| New | +$206K |
|
9998
PUT
Wave Life Sciences
WVE
$1.03B
| $207K | ﹤0.01% |
25,300
+9,600
| +61% | +$57.4K |
|
9999
PUT
Rollins
ROL
$17.3B
| $207K | ﹤0.01% |
4,100
-48,300
| -92% | -$2.39M |
|
10000
IMGP Berkshire Dividend Growth ETF
BDVG
$21.3M
| $207K | ﹤0.01% |
17,762
-804
| -4% | -$9.13K |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,610 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.